No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs6138652 |
chr20:25731063-25731064 |
Enhancers Active TSS Weak transcription Flanking Active TSS
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs542634457 |
chr20:25731160-25731161 |
Enhancers Active TSS Weak transcription Flanking Active TSS
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs558740817 |
chr20:25731183-25731184 |
Enhancers Active TSS Weak transcription Flanking Active TSS
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs186251946 |
chr20:25731190-25731191 |
Enhancers Active TSS Weak transcription Flanking Active TSS
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs577438728 |
chr20:25731228-25731229 |
Active TSS Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs528569084 |
chr20:25731241-25731242 |
Active TSS Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs551813670 |
chr20:25731248-25731249 |
Active TSS Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs541569603 |
chr20:25731273-25731274 |
Active TSS Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs565383633 |
chr20:25731294-25731295 |
Active TSS Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs35016365 |
chr20:25731296-25731297 |
Active TSS Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer
|
TF binding regionlncRNA
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
11 |
rs573642289 |
chr20:25731314-25731315 |
Active TSS Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs372598712 |
chr20:25731319-25731320 |
Active TSS Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs574821662 |
chr20:25731384-25731385 |
Active TSS Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs6115276 |
chr20:25731401-25731402 |
Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs60744587 |
chr20:25731429-25731430 |
Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
16 |
rs6115277 |
chr20:25731440-25731441 |
Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs6115278 |
chr20:25731489-25731490 |
Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs567543438 |
chr20:25731505-25731506 |
Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs541846539 |
chr20:25731506-25731507 |
Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs141312693 |
chr20:25731510-25731511 |
Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs57150489 |
chr20:25731671-25731672 |
Active TSS Bivalent/Poised TSS Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
22 |
rs538257717 |
chr20:25731694-25731695 |
Active TSS Bivalent/Poised TSS Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs558201460 |
chr20:25731712-25731713 |
Active TSS Bivalent/Poised TSS Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs564016440 |
chr20:25731729-25731730 |
Active TSS Bivalent/Poised TSS Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs575010667 |
chr20:25731742-25731743 |
Active TSS Bivalent/Poised TSS Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs369409506 |
chr20:25731767-25731768 |
Active TSS Bivalent/Poised TSS Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs557160804 |
chr20:25731819-25731820 |
Active TSS Bivalent/Poised TSS Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs556492701 |
chr20:25731832-25731833 |
Active TSS Bivalent/Poised TSS Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs372050261 |
chr20:25731846-25731847 |
Active TSS Bivalent/Poised TSS Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs575484542 |
chr20:25731869-25731870 |
Active TSS Bivalent/Poised TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs77584066 |
chr20:25731875-25731876 |
Active TSS Bivalent/Poised TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs370846516 |
chr20:25731938-25731939 |
Active TSS Bivalent/Poised TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs191824429 |
chr20:25731955-25731956 |
Active TSS Bivalent/Poised TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs564307260 |
chr20:25731990-25731991 |
Active TSS Bivalent/Poised TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs199906708 |
chr20:25731996-25731997 |
Active TSS Bivalent/Poised TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs79601323 |
chr20:25732026-25732027 |
Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs200666859 |
chr20:25732070-25732071 |
Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs145046246 |
chr20:25732072-25732073 |
Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs545443773 |
chr20:25732150-25732151 |
Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs565346993 |
chr20:25732160-25732161 |
Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs183235737 |
chr20:25732238-25732239 |
Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs576040709 |
chr20:25732243-25732244 |
Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs76603506 |
chr20:25732267-25732268 |
Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs551276382 |
chr20:25732283-25732284 |
Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs66983770 |
chr20:25732343-25732344 |
Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
46 |
rs80216239 |
chr20:25732385-25732386 |
Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs529856397 |
chr20:25732403-25732404 |
Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs114175690 |
chr20:25732430-25732431 |
Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs138984769 |
chr20:25732443-25732444 |
Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs532098006 |
chr20:25732461-25732462 |
Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|